ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: It has been shown that overexpressed lncRNA UCA1 modulates CML-imatinib resistance by acting as a competitive endogenous RNA (ceRNA) against miR-16, and this in turn stimulates MDR1 expression and alters the drug efflux system [123].